Business Wire

BostonGene Evaluates Novel Therapies and Immune System Profiling as a Marker of Response in Patients with Gastrointestinal Cancers

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, and Georgetown University’s Lombardi Comprehensive Cancer Center today announced ...
ascopubs.org

AI-based predictive tool for identifying druggable mutations in lung cancer using nationwide comprehensive genomic profiling data.

Real-world baseline characteristics and diagnostic path of Polish patients with ALK-positive NSCLC eligible for brigatinib treatment: Interim results from the ENTIRETY study. This is an ASCO Meeting ...
ascopubs.org

Combined high-resolution H3K27ac epigenomic and single-cell transcriptional profiling as a signature predictive of response to neoadjuvant immune checkpoint inhibitors (ICI) in ...

Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
Publishers Weekly

Profiling: How Predictive Algorithms Shape Identity and the Social Fabric

This demanding study from Huneman (Why?), director of research at the Institute of History and Philosophy of Science and Technology in Paris, examines how predictive algorithms influence identity and ...